CAS 491577-61-8

Benzenecarboximidamide,N-hydroxy-4-[[5-[4-[2-methyl-5-(1-methylethyl)-4-thiazolyl]phenoxy]pentyl]oxy]-

Description:

Benzenecarboximidamide, N-hydroxy-4-[[5-[4-[2-methyl-5-(1-methylethyl)-4-thiazolyl]phenoxy]pentyl]oxy]- is a complex organic compound characterized by its unique structural features, which include a benzenecarboximidamide core and various functional groups such as hydroxyl and thiazole moieties. This compound is likely to exhibit properties typical of amides, including potential solubility in polar solvents and the ability to participate in hydrogen bonding due to the presence of the hydroxyl group. The thiazole ring may contribute to its biological activity, possibly influencing its interaction with biological targets. Additionally, the presence of alkyl groups, such as the isopropyl group, may enhance lipophilicity, affecting its pharmacokinetic properties. The compound's complexity suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals. However, specific data regarding its reactivity, stability, and biological activity would require further investigation through experimental studies and characterization techniques.

Formula: C₂₅H₃₁N₃O₃S

N-Hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine

CAS: 491577-61-8

N-Hydroxy-4-[5-(4-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxybenzamidine is a substance that has been shown to have an inhibitory effect on the production of proinflammatory cytokines and chemokines in vitro. It has been studied as a potential treatment for inflammatory diseases, such as rheumatoid arthritis. N-Hydroxy-4-[5-(4-isopropyl-2-methyl-1,3-thiazol-4--yl)phenoxy]pentoxybenzamidine is also known as alendronic acid and is used to treat osteoporosis. It can be administered orally or perorally and is often given in combination with alendronic acid or other drugs.

Formula: C₂₅H₃₁N₃O₃S

Purity: Min. 95%

Molecular weight: 453.6 g/mol

Ref: 3D-RUA57761

DW-1350

CAS: 491577-61-8

DW-1350 is an antagonist of LTB4 receptor.

Formula: C₂₅H₃₁N₃O₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 453.6

Ref: TM-T15182